TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs10486187
log Bayes Factor = 0.00981245
Chromosome 7   position 7,779,324  (GRCh37) Explore rs10486187 on Ensembl!
Variant rs10486187 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
N43.3 Hydrocele, unspecified
0.073 0.927 0.000
M79.86 Other specified soft tissue disorders (Lower leg)
0.000 0.959 0.041
N43 Hydrocele and spermatocele
0.039 0.961 0.000
N43.4 Spermatocele
0.029 0.970 0.000
N43.2 Other hydrocele
0.028 0.972 0.000
N43.1 Infected hydrocele
0.028 0.972 0.000
N43.0 Encysted hydrocele
0.028 0.972 0.000
F10.0 Acute intoxication
0.000 0.976 0.024
M79.8 Other specified soft tissue disorders
0.000 0.987 0.013
M79.84 Other specified soft tissue disorders (Hand)
0.000 0.988 0.012
N45.9 Orchitis, epididymitis and epididymo-orchitis without abscess
0.011 0.989 0.000
N45 Orchitis and epididymitis
0.011 0.989 0.000
M79.80 Other specified soft tissue disorders (Multiple sites)
0.000 0.989 0.011
N40-N51 Diseases of male genital organs
0.011 0.989 0.000
M79.87 Other specified soft tissue disorders (Ankle and foot)
0.000 0.990 0.010
N49 Inflammatory disorders of male genital organs, not elsewhere classified
0.010 0.990 0.000
M79.81 Other specified soft tissue disorders (Shoulder region)
0.000 0.991 0.009
O34.2 Maternal care due to uterine scar from previous surgery
0.000 0.991 0.009
F10 Mental and behavioural disorders due to use of alcohol
0.000 0.991 0.009
G93.8 Other specified disorders of brain
0.009 0.991 0.000
M79.83 Other specified soft tissue disorders (Forearm)
0.000 0.991 0.009
C91.1 Chronic lymphocytic leukaemia
0.009 0.991 0.000
N45.0 Orchitis, epididymitis and epididymo-orchitis with abscess
0.008 0.991 0.000
N49.8 Inflammatory disorders of other specified male genital organs
0.008 0.992 0.000
F10.3 Withdrawal state
0.000 0.992 0.008
G93 Other disorders of brain
0.008 0.992 0.000
M79.82 Other specified soft tissue disorders (Upper arm)
0.000 0.992 0.008
N50 Other disorders of male genital organs
0.008 0.992 0.000
G93.6 Cerebral oedema
0.008 0.992 0.000
N49.2 Inflammatory disorders of scrotum
0.008 0.992 0.000
N51 Disorders of male genital organs in diseases classified elsewhere
0.008 0.992 0.000
N44 Torsion of testis
0.008 0.992 0.000
F10.2 Dependence syndrome
0.000 0.992 0.008
C83 Diffuse non-Hodgkin's lymphoma
0.008 0.992 0.000
M79.89 Other specified soft tissue disorders (Site unspecified)
0.000 0.992 0.007
T50.9 Other and unspecified drugs, medicaments and biological substances
0.000 0.992 0.008
G93.4 Encephalopathy, unspecified
0.008 0.992 0.000
M79.88 Other specified soft tissue disorders (Other)
0.000 0.993 0.007
F10.4 Withdrawal state with delirium
0.000 0.993 0.007
N13.1 Hydronephrosis with ureteral stricture, not elsewhere classified
0.007 0.993 0.000
T42.4 Benzodiazepines
0.000 0.993 0.007
G93.5 Compression of brain
0.007 0.993 0.000
N49.9 Inflammatory disorder of unspecified male genital organ
0.007 0.993 0.000
N49.1 Inflammatory disorders of spermatic cord, tunica vaginalis and vas deferens
0.007 0.993 0.000
N49.0 Inflammatory disorders of seminal vesicle
0.007 0.993 0.000
N50.9 Disorder of male genital organs, unspecified
0.007 0.993 0.000
N46 Male infertility
0.007 0.993 0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.000 0.993 0.007
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified
0.007 0.993 0.000
N41 Inflammatory diseases of prostate
0.007 0.993 0.000
N42 Other disorders of prostate
0.007 0.993 0.000
F10.8 Other mental and behavioural disorders
0.000 0.993 0.007
F10.7 Residual and late-onset psychotic disorder
0.000 0.993 0.007
G93.2 Benign intracranial hypertension
0.007 0.993 0.000
C83.3 Large cell (diffuse)
0.007 0.993 0.000
T36-T50 Poisoning by drugs, medicaments and biological substances
0.000 0.993 0.007
N42.8 Other specified disorders of prostate
0.007 0.993 0.000
F10.5 Psychotic disorder
0.000 0.993 0.007
C91 Lymphoid leukaemia
0.007 0.993 0.000
G93.1 Anoxic brain damage, not elsewhere classified
0.007 0.993 0.000
C83.0 Small cell (diffuse)
0.007 0.993 0.000
N80.3 Endometriosis of pelvic peritoneum
0.007 0.993 0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.000 0.993 0.007
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.000 0.993 0.007
F10.9 Unspecified mental and behavioural disorder
0.000 0.993 0.006
N13 Obstructive and reflux uropathy
0.007 0.993 0.000
C83.1 Small cleaved cell (diffuse)
0.006 0.993 0.000
M79.85 Other specified soft tissue disorders (Pelvic region and thigh)
0.000 0.994 0.006
N50.8 Other specified disorders of male genital organs
0.006 0.994 0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma
0.006 0.994 0.000
G93.7 Reye's syndrome
0.006 0.994 0.000
N50.0 Atrophy of testis
0.006 0.994 0.000
F10.6 Amnesic syndrome
0.000 0.994 0.006
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.000 0.994 0.006
N42.2 Atrophy of prostate
0.006 0.994 0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.000 0.994 0.006
T46 Poisoning by agents primarily affecting the cardiovascular system
0.000 0.994 0.006
T81.2 Accidental puncture and laceration during a procedure, not elsewhere classified
0.000 0.994 0.006
N13.3 Other and unspecified hydronephrosis
0.006 0.994 0.000
Z53.9 Procedure not carried out, unspecified reason
0.006 0.994 0.000
N51.8 Other disorders of male genital organs in diseases classified elsewhere
0.006 0.994 0.000
N51.2 Balanitis in diseases classified elsewhere
0.006 0.994 0.000
N51.1 Disorders of testis and epididymis in diseases classified elsewhere
0.006 0.994 0.000
N51.0 Disorders of prostate in diseases classified elsewhere
0.006 0.994 0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.000 0.994 0.006
C83.7 Burkitt's tumour
0.006 0.994 0.000
T43.3 Phenothiazine antipsychotics and neuroleptics
0.000 0.994 0.006
N41.0 Acute prostatitis
0.006 0.994 0.000
N13.7 Vesicoureteral-reflux-associated uropathy
0.006 0.994 0.000
T43.5 Other and unspecified antipsychotics and neuroleptics
0.000 0.994 0.006
C83.6 Undifferentiated (diffuse)
0.006 0.994 0.000
C83.5 Lymphoblastic (diffuse)
0.006 0.994 0.000
C83.4 Immunoblastic (diffuse)
0.006 0.994 0.000
C83.2 Mixed small and large cell (diffuse)
0.006 0.994 0.000
N13.8 Other obstructive and reflux uropathy
0.006 0.994 0.000
N40 Hyperplasia of prostate
0.006 0.994 0.000
N41.1 Chronic prostatitis
0.006 0.994 0.000
T46.4 Angiotensin-converting-enzyme inhibitors
0.000 0.994 0.006
M41.99 Scoliosis, unspecified (Site unspecified)
0.000 0.994 0.006
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.006 0.994 0.000
C91.0 Acute lymphoblastic leukaemia
0.005 0.995 0.000
C81.9 Hodgkin's disease, unspecified
0.005 0.995 0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.000 0.995 0.005
T50.8 Diagnostic agents
0.000 0.995 0.005
T50.7 Analeptics and opioid receptor antagonists
0.000 0.995 0.005
T50.6 Antidotes and chelating agents, not elsewhere classified
0.000 0.995 0.005
T50.5 Appetite depressants
0.000 0.995 0.005
T50.4 Drugs affecting uric acid metabolism
0.000 0.995 0.005
T50.3 Electrolytic, caloric and water-balance agents
0.000 0.995 0.005
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.000 0.995 0.005
T50.1 Loop [high-ceiling] diuretics
0.000 0.995 0.005
T50.0 Mineralocorticoids and their antagonists
0.000 0.995 0.005
N13.2 Hydronephrosis with renal and ureteral calculous obstruction
0.005 0.995 0.000
N41.8 Other inflammatory diseases of prostate
0.005 0.995 0.000
N41.3 Prostatocystitis
0.005 0.995 0.000
N41.2 Abscess of prostate
0.005 0.995 0.000
N42.3 Dysplasia of prostate
0.005 0.995 0.000
N13.6 Pyonephrosis
0.005 0.995 0.000
G90-G99 Other disorders of the nervous system
0.005 0.995 0.000
C81 Hodgkin's disease
0.005 0.995 0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.000 0.995 0.005
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.000 0.995 0.005
T41 Poisoning by anaesthetics and therapeutic gases
0.000 0.995 0.005
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.000 0.995 0.005
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.000 0.995 0.005
T43.0 Tricyclic and tetracyclic antidepressants
0.000 0.995 0.005
N13.0 Hydronephrosis with ureteropelvic junction obstruction
0.005 0.995 0.000
C91.9 Lymphoid leukaemia, unspecified
0.005 0.995 0.000
C91.8 Mature B-cell leukaemia Burkitt-type
0.005 0.995 0.000
C91.7 Other lymphoid leukaemia
0.005 0.995 0.000
C91.6 Prolymphocytic leukaemia of T-cell type
0.005 0.995 0.000
C91.5 Adult T-cell leukaemia
0.005 0.995 0.000
C91.3 Prolymphocytic leukaemia
0.005 0.995 0.000
C91.2 Subacute lymphocytic leukaemia
0.005 0.995 0.000
T43.4 Butyrophenone and thioxanthene neuroleptics
0.000 0.995 0.005
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.000 0.995 0.005
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.000 0.995 0.005
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.000 0.995 0.005
T42.5 Mixed antiepileptics, not elsewhere classified
0.000 0.995 0.005
T42.3 Barbiturates
0.000 0.995 0.005
T42.2 Succinimides and oxazolidinediones
0.000 0.995 0.005
T42.1 Iminostilbenes
0.000 0.995 0.005
T43.9 Psychotropic drug, unspecified
0.000 0.995 0.005
T43.8 Other psychotropic drugs, not elsewhere classified
0.000 0.995 0.005
T43.6 Psychostimulants with abuse potential
0.000 0.995 0.005
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.000 0.995 0.005
T36 Poisoning by systemic antibiotics
0.000 0.995 0.005
G93.9 Disorder of brain, unspecified
0.005 0.995 0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.000 0.995 0.005
M41.9 Scoliosis, unspecified
0.000 0.995 0.005
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.000 0.995 0.005
T42.0 Hydantoin derivatives
0.000 0.995 0.005
M41.96 Scoliosis, unspecified (Lumbar region)
0.000 0.995 0.005
T39.1 4-Aminophenol derivatives
0.000 0.995 0.005
C88 Malignant immunoproliferative diseases
0.005 0.995 0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.000 0.995 0.005
T39.4 Antirheumatics, not elsewhere classified
0.000 0.995 0.005
T39.2 Pyrazolone derivatives
0.000 0.995 0.005
T43.2 Other and unspecified antidepressants
0.000 0.995 0.005
G98 Other disorders of nervous system, not elsewhere classified
0.005 0.995 0.000
T38.9 Other and unspecified hormone antagonists
0.000 0.995 0.004
T38.8 Other and unspecified hormones and their synthetic substitutes
0.000 0.995 0.004
T38.7 Androgens and anabolic congeners
0.000 0.995 0.004
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.000 0.995 0.004
T38.5 Other oestrogens and progestogens
0.000 0.995 0.004
T38.4 Oral contraceptives
0.000 0.995 0.004
T38.2 Antithyroid drugs
0.000 0.995 0.004
T38.1 Thyroid hormones and substitutes
0.000 0.995 0.004
T38.0 Glucocorticoids and synthetic analogues
0.000 0.995 0.004
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.000 0.995 0.004
T46.8 Antivaricose drugs, including sclerosing agents
0.000 0.995 0.004
T46.7 Peripheral vasodilators
0.000 0.995 0.004
T46.5 Other antihypertensive drugs, not elsewhere classified
0.000 0.995 0.004
T46.3 Coronary vasodilators, not elsewhere classified
0.000 0.995 0.004
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.000 0.995 0.004
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.000 0.995 0.004
N13.4 Hydroureter
0.004 0.995 0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.000 0.995 0.004
R59.1 Generalised enlarged lymph nodes
0.005 0.995 0.000
R74.8 Abnormal levels of other serum enzymes
0.004 0.995 0.000
G96 Other disorders of central nervous system
0.004 0.995 0.000
N42.0 Calculus of prostate
0.004 0.996 0.000
T45.0 Antiallergic and antiemetic drugs
0.000 0.996 0.004
G91 Hydrocephalus
0.004 0.996 0.000
G94 Other disorders of brain in diseases classified elsewhere
0.004 0.996 0.000
C93 Monocytic leukaemia
0.004 0.996 0.000
G97 Postprocedural disorders of nervous system, not elsewhere classified
0.004 0.996 0.000
T40.6 Other and unspecified narcotics
0.000 0.996 0.004
C91.4 Hairy-cell leukaemia
0.004 0.996 0.000
G93.0 Cerebral cysts
0.004 0.996 0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.004 0.996 0.000
C94 Other leukaemias of specified cell type
0.004 0.996 0.000
C86 Other specified types of T/NK-cell lymphoma
0.004 0.996 0.000
G93.3 Postviral fatigue syndrome
0.004 0.996 0.000
N13.9 Obstructive and reflux uropathy, unspecified
0.004 0.996 0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.000 0.996 0.004
C95 Leukaemia of unspecified cell type
0.004 0.996 0.000
C88.0 Waldenstrom's macroglobulinaemia
0.004 0.996 0.000
T39.0 Salicylates
0.000 0.996 0.004
G99 Other disorders of nervous system in diseases classified elsewhere
0.004 0.996 0.000
G92 Toxic encephalopathy
0.004 0.996 0.000
G91.0 Communicating hydrocephalus
0.004 0.996 0.000
C81.7 Other Hodgkin's disease
0.004 0.996 0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma
0.004 0.996 0.000
C81.3 Lymphocytic depletion
0.004 0.996 0.000
C81.2 Mixed cellularity
0.004 0.996 0.000
C81.0 Lymphocytic predominance
0.004 0.996 0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.000 0.996 0.004
T37.8 Other specified systemic anti-infectives and antiparasitics
0.000 0.996 0.004
T37.5 Antiviral drugs
0.000 0.996 0.004
T37.4 Anthelminthics
0.000 0.996 0.004
T37.3 Other antiprotozoal drugs
0.000 0.996 0.004
T37.2 Antimalarials and drugs acting on other blood protozoa
0.000 0.996 0.004
T37.1 Antimycobacterial drugs
0.000 0.996 0.004
T37.0 Sulphonamides
0.000 0.996 0.004
T41.5 Therapeutic gases
0.000 0.996 0.004
T41.4 Anaesthetic, unspecified
0.000 0.996 0.004
T41.3 Local anaesthetics
0.000 0.996 0.004
T41.2 Other and unspecified general anaesthetics
0.000 0.996 0.004
T41.1 Intravenous anaesthetics
0.000 0.996 0.004
T41.0 Inhaled anaesthetics
0.000 0.996 0.004
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.000 0.996 0.004
T48.6 Antiasthmatics, not elsewhere classified
0.000 0.996 0.004
T48.5 Anti-common-cold drugs
0.000 0.996 0.004
T48.4 Expectorants
0.000 0.996 0.004
T48.3 Antitussives
0.000 0.996 0.004
T48.2 Other and unspecified agents primarily acting on muscles
0.000 0.996 0.004
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.000 0.996 0.004
T48.0 Oxytocic drugs
0.000 0.996 0.004
T49.9 Topical agent, unspecified
0.000 0.996 0.004
T49.8 Other topical agents
0.000 0.996 0.004
T49.7 Dental drugs, topically applied
0.000 0.996 0.004
T49.6 Otorhinolaryngological drugs and preparations
0.000 0.996 0.004
T49.5 Ophthalmological drugs and preparations
0.000 0.996 0.004
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.000 0.996 0.004
T49.3 Emollients, demulcents and protectants
0.000 0.996 0.004
T49.2 Local astringents and local detergents
0.000 0.996 0.004
T49.1 Antipruritics
0.000 0.996 0.004
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.000 0.996 0.004
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.000 0.996 0.004
T40.8 Lysergide [LSD]
0.000 0.996 0.004
T40.7 Cannabis (derivatives)
0.000 0.996 0.004
T40.5 Cocaine
0.000 0.996 0.004
T40.3 Methadone
0.000 0.996 0.004
T40.1 Heroin
0.000 0.996 0.004
T40.0 Opium
0.000 0.996 0.004
T40.2 Other opioids
0.000 0.996 0.004
N84.1 Polyp of cervix uteri
0.000 0.996 0.004
T45.9 Primarily systemic and haematological agent, unspecified
0.000 0.996 0.004
T45.8 Other primarily systemic and haematological agents
0.000 0.996 0.004
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.000 0.996 0.004
T45.6 Fibrinolysis-affecting drugs
0.000 0.996 0.004
T45.4 Iron and its compounds
0.000 0.996 0.004
T45.3 Enzymes, not elsewhere classified
0.000 0.996 0.004
G96.1 Disorders of meninges, not elsewhere classified
0.004 0.996 0.000
J93.9 Pneumothorax, unspecified
0.004 0.996 0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.004 0.996 0.000
C84 Peripheral and cutaneous T-cell lymphomas
0.004 0.996 0.000
T36.9 Systemic antibiotic, unspecified
0.000 0.996 0.004
T36.8 Other systemic antibiotics
0.000 0.996 0.004
T36.7 Antifungal antibiotics, systemically used
0.000 0.996 0.004
T36.6 Rifamycins
0.000 0.996 0.004
T36.5 Aminoglycosides
0.000 0.996 0.004
T36.4 Tetracyclines
0.000 0.996 0.004
T36.3 Macrolides
0.000 0.996 0.004
T36.2 Chloramphenicol group
0.000 0.996 0.004
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.000 0.996 0.004
E05.0 Thyrotoxicosis with diffuse goitre
0.004 0.996 0.000
G94.2 Hydrocephalus in other diseases classified elsewhere
0.004 0.996 0.000
T46.1 Calcium-channel blockers
0.000 0.996 0.004
M41.95 Scoliosis, unspecified (Thoracolumbar region)
0.000 0.996 0.004
N13.5 Kinking and stricture of ureter without hydronephrosis
0.004 0.996 0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.000 0.996 0.004
T47.8 Other agents primarily affecting the gastro-intestinal system
0.000 0.996 0.004
T47.7 Emetics
0.000 0.996 0.004
T47.6 Antidiarrhoeal drugs
0.000 0.996 0.004
T47.5 Digestants
0.000 0.996 0.004
T47.4 Other laxatives
0.000 0.996 0.004
T47.3 Saline and osmotic laxatives
0.000 0.996 0.004
T47.2 Stimulant laxatives
0.000 0.996 0.004
T47.0 Histamine H(2)-receptor antagonists
0.000 0.996 0.004
M41.98 Scoliosis, unspecified (Sacral and sacrococcygeal region)
0.000 0.996 0.004
M41.97 Scoliosis, unspecified (Lumbosacral region)
0.000 0.996 0.004
M41.93 Scoliosis, unspecified (Cervicothoracic region)
0.000 0.996 0.004
M41.92 Scoliosis, unspecified (Cervical region)
0.000 0.996 0.004
M41.91 Scoliosis, unspecified (Occipito-atlanto-axial region)
0.000 0.996 0.004
M41.90 Scoliosis, unspecified (Multiple sites in spine)
0.000 0.996 0.004
G04.9 Encephalitis, myelitis and encephalomyelitis, unspecified
0.004 0.996 0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.000 0.996 0.004
T45.1 Antineoplastic and immunosuppressive drugs
0.000 0.996 0.004
E05.9 Thyrotoxicosis, unspecified
0.004 0.996 0.000
N48.9 Disorder of penis, unspecified
0.004 0.996 0.000
G95 Other diseases of spinal cord
0.004 0.996 0.000
G91.2 Normal-pressure hydrocephalus
0.004 0.996 0.000
N48 Other disorders of penis
0.004 0.996 0.000
N50.1 Vascular disorders of male genital organs
0.004 0.996 0.000
C88.9 Malignant immunoproliferative disease, unspecified
0.003 0.996 0.000
C88.7 Other malignant immunoproliferative diseases
0.003 0.996 0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]
0.003 0.996 0.000
C88.3 Immunoproliferative small intestinal disease
0.003 0.996 0.000
C88.2 Gamma heavy chain disease
0.003 0.996 0.000
C88.1 Alpha heavy chain disease
0.003 0.996 0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.004 0.996 0.000
R76.8 Other specified abnormal immunological findings in serum
0.004 0.996 0.000
R74 Abnormal serum enzyme levels
0.004 0.996 0.000
G97.8 Other postprocedural disorders of nervous system
0.003 0.996 0.000
G99.2 Myelopathy in diseases classified elsewhere
0.004 0.996 0.000
H60.9 Otitis externa, unspecified
0.004 0.996 0.000
T40.4 Other synthetic narcotics
0.000 0.996 0.003
S01.0 Open wound of scalp
0.000 0.996 0.004
T45.5 Anticoagulants
0.000 0.996 0.003
M41.94 Scoliosis, unspecified (Thoracic region)
0.000 0.996 0.003
C93.1 Chronic monocytic leukaemia
0.003 0.996 0.000
G96.0 Cerebrospinal fluid leak
0.003 0.996 0.000
T36.0 Penicillins
0.000 0.996 0.003
E05 Thyrotoxicosis [hyperthyroidism]
0.004 0.996 0.000
C81.1 Nodular sclerosis
0.003 0.996 0.000
G96.9 Disorder of central nervous system, unspecified
0.003 0.996 0.000
G96.8 Other specified disorders of central nervous system
0.003 0.996 0.000
N48.4 Impotence of organic origin
0.003 0.996 0.000
T45.2 Vitamins, not elsewhere classified
0.000 0.997 0.003
G97.0 Cerebrospinal fluid leak from spinal puncture
0.003 0.997 0.000
G91.8 Other hydrocephalus
0.003 0.997 0.000
G91.3 Posttraumatic hydrocephalus, unspecified
0.003 0.997 0.000
N42.1 Congestion and haemorrhage of prostate
0.003 0.997 0.000
G91.9 Hydrocephalus, unspecified
0.003 0.997 0.000
G94.8 Other specified disorders of brain in diseases classified elsewhere
0.003 0.997 0.000
G94.0 Hydrocephalus in infectious and parasitic diseases classified elsewhere
0.003 0.997 0.000
C93.9 Monocytic leukaemia, unspecified
0.003 0.997 0.000
C93.7 Other monocytic leukaemia
0.003 0.997 0.000
C93.3 Juvenile myelomonocytic leukaemia
0.003 0.997 0.000
C93.2 Subacute monocytic leukaemia
0.003 0.997 0.000
C93.0 Acute monocytic leukaemia
0.003 0.997 0.000
T47.1 Other antacids and anti-gastric-secretion drugs
0.000 0.997 0.003
Y45.0 Opioids and related analgesics
0.000 0.997 0.003
G94.1 Hydrocephalus in neoplastic disease
0.003 0.997 0.000
G97.9 Postprocedural disorder of nervous system, unspecified
0.003 0.997 0.000
G97.2 Intracranial hypotension following ventricular shunting
0.003 0.997 0.000
R76 Other abnormal immunological findings in serum
0.003 0.997 0.000
G95.2 Cord compression, unspecified
0.003 0.997 0.000
J98.4 Other disorders of lung
0.000 0.997 0.003
G97.1 Other reaction to spinal and lumbar puncture
0.003 0.997 0.000
M43.16 Spondylolisthesis (Lumbar region)
0.000 0.997 0.003
C86.6 Primary cutaneous CD30-positive T-cell proliferations
0.003 0.997 0.000
C86.5 Angioimmunoblastic T-cell lymphoma
0.003 0.997 0.000
C86.4 Blastic NK-cell lymphoma
0.003 0.997 0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma
0.003 0.997 0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma
0.003 0.997 0.000
C86.1 Hepatosplenic T-cell lymphoma
0.003 0.997 0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type
0.003 0.997 0.000
C94.7 Other specified leukaemias
0.003 0.997 0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified
0.003 0.997 0.000
C94.5 Acute myelofibrosis
0.003 0.997 0.000
C94.4 Acute panmyelosis
0.003 0.997 0.000
C94.3 Mast cell leukaemia
0.003 0.997 0.000
C94.2 Acute megakaryoblastic leukaemia
0.003 0.997 0.000
C94.1 Chronic erythraemia
0.003 0.997 0.000
C94.0 Acute erythraemia and erythroleukaemia
0.003 0.997 0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified
0.003 0.997 0.000
C96.8 Histiocytic sarcoma
0.003 0.997 0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.003 0.997 0.000
C96.6 Unifocal Langerhans-cell histiocytosis
0.003 0.997 0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis
0.003 0.997 0.000
C96.4 Sarcoma of dendritic cells (accessory cells)
0.003 0.997 0.000
C96.3 True histiocytic lymphoma
0.003 0.997 0.000
C96.2 Malignant mast cell tumour
0.003 0.997 0.000
C96.1 Malignant histiocytosis
0.003 0.997 0.000
C96.0 Letterer-Siwe disease
0.003 0.997 0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.000 0.997 0.003
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.000 0.997 0.003
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.997 0.003
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.000 0.997 0.003
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.000 0.997 0.003
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.000 0.997 0.003
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.000 0.997 0.003
T44.1 Other parasympathomimetics [cholinergics]
0.000 0.997 0.003
T44.0 Anticholinesterase agents
0.000 0.997 0.003
C95.7 Other leukaemia of unspecified cell type
0.003 0.997 0.000
C95.2 Subacute leukaemia of unspecified cell type
0.003 0.997 0.000
C95.1 Chronic leukaemia of unspecified cell type
0.003 0.997 0.000
C95.0 Acute leukaemia of unspecified cell type
0.003 0.997 0.000
G99.8 Other specified disorders of nervous system in diseases classified elsewhere
0.003 0.997 0.000
G99.1 Other disorders of autonomic nervous system in other diseases classified elsewhere
0.003 0.997 0.000
M41 Scoliosis
0.000 0.997 0.003
M43.1 Spondylolisthesis
0.000 0.997 0.003
C90 Multiple myeloma and malignant plasma cell neoplasms
0.003 0.997 0.000
C82.2 Large cell, follicular
0.003 0.997 0.000
G04 Encephalitis, myelitis and encephalomyelitis
0.003 0.997 0.000
C95.9 Leukaemia, unspecified
0.003 0.997 0.000
C71.8 Overlapping lesion of brain
0.003 0.997 0.000
R76.0 Raised antibody titer
0.003 0.997 0.000
N48.5 Ulcer of penis
0.003 0.997 0.000
M43.17 Spondylolisthesis (Lumbosacral region)
0.000 0.997 0.003
C85.1 B-cell lymphoma, unspecified
0.003 0.997 0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.003 0.997 0.000
C85.0 Lymphosarcoma
0.003 0.997 0.000
C84.9 Mature T/NK-cell lymphoma, unspecified
0.003 0.997 0.000
C84.8 Cutaneous T-cell lymphoma, unspecified
0.003 0.997 0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative
0.003 0.997 0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive
0.003 0.997 0.000
C84.4 Peripheral T-cell lymphoma
0.003 0.997 0.000
C84.3 Lymphoepithelioid lymphoma
0.003 0.997 0.000
C84.2 T-zone lymphoma
0.003 0.997 0.000
C84.1 Sezary's diease
0.003 0.997 0.000
C84.0 Mycosis fungoides
0.003 0.997 0.000
R74.0 Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]
0.003 0.997 0.000
C71.1 Frontal lobe
0.003 0.997 0.000
G95.0 Syringomyelia and syringobulbia
0.003 0.997 0.000
C71 Malignant neoplasm of brain
0.003 0.997 0.000
N48.3 Priapism
0.003 0.997 0.000
O20.9 Haemorrhage in early pregnancy, unspecified
0.003 0.997 0.000
I51.9 Heart disease, unspecified
0.000 0.997 0.003
L57.0 Actinic keratosis
0.000 0.997 0.003
C82.6 Cutaneous follicle centre lymphoma
0.003 0.997 0.000
C82.5 Diffuse follicle centre lymphoma
0.003 0.997 0.000
C82.4 Follicular lymphoma grade IIIb
0.003 0.997 0.000
C82.3 Follicular lymphoma grade IIIa
0.003 0.997 0.000
C82.0 Small cleaved cell, follicular
0.003 0.997 0.000
R74.9 Abnormal level of unspecified serum enzyme
0.003 0.997 0.000
M43.19 Spondylolisthesis (Site unspecified)
0.000 0.997 0.003
C82.1 Mixed small cleaved and large cell, follicular
0.003 0.997 0.000
R79.9 Abnormal finding of blood chemistry, unspecified
0.003 0.997 0.000
R70-R79 Abnormal findings on examination of blood, without diagnosis
0.003 0.997 0.000
N10-N16 Renal tubulo-interstitial diseases
0.003 0.997 0.000
E05.5 Thyroid crisis or storm
0.003 0.997 0.000
E05.4 Thyrotoxicosis factitia
0.003 0.997 0.000
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.003 0.997 0.000
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.003 0.997 0.000
G95.8 Other specified diseases of spinal cord
0.003 0.997 0.000
G99.0 Autonomic neuropathy in endocrine and metabolic diseases
0.003 0.997 0.000
C92 Myeloid leukaemia
0.002 0.997 0.001
C71.4 Occipital lobe
0.003 0.997 0.000
C85.7 Other specified types of non-Hodgkin's lymphoma
0.003 0.997 0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.003 0.997 0.000
E05.8 Other thyrotoxicosis
0.003 0.997 0.000
G95.1 Vascular myelopathies
0.003 0.997 0.000
G00-G09 Inflammatory diseases of the central nervous system
0.003 0.997 0.000
R76.9 Abnormal immunological finding in serum, unspecified
0.003 0.997 0.000
R76.2 False-positive serological test for syphilis
0.003 0.997 0.000
R76.1 Abnormal reaction to tuberculin test
0.003 0.997 0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma
0.003 0.997 0.000
C90.2 Plasmacytoma, extramedullary
0.003 0.997 0.000
E05.2 Thyrotoxicosis with toxic multinodular goitre
0.003 0.997 0.000
C71.2 Temporal lobe
0.003 0.997 0.000
N15 Other renal tubulo-interstitial diseases
0.003 0.997 0.000
O34 Maternal care for known or suspected abnormality of pelvic organs
0.000 0.997 0.003
H60 Otitis externa
0.003 0.997 0.000
C84.5 Other and unspecified T-cell lymphomas
0.002 0.997 0.000
E04.9 Non-toxic goitre, unspecified
0.003 0.997 0.000
G91.1 Obstructive hydrocephalus
0.002 0.997 0.000
N48.0 Leukoplakia of penis
0.002 0.997 0.000
G90 Disorders of autonomic nervous system
0.002 0.997 0.000
M43 Other deforming dorsopathies
0.000 0.997 0.003
C71.3 Parietal lobe
0.003 0.997 0.000
M41.5 Other secondary scoliosis
0.000 0.997 0.002
M41.4 Neuromuscular scoliosis
0.000 0.997 0.002
M41.3 Thoracogenic scoliosis
0.000 0.997 0.002
M41.2 Other idiopathic scoliosis
0.000 0.997 0.002
M41.1 Juvenile idiopathic scoliosis
0.000 0.997 0.002
M41.0 Infantile idiopathic scoliosis
0.000 0.997 0.002
N41.9 Inflammatory disease of prostate, unspecified
0.002 0.997 0.000
E04 Other non-toxic goitre
0.003 0.997 0.000
M43.18 Spondylolisthesis (Sacral and sacrococcygeal region)
0.000 0.997 0.002
M43.15 Spondylolisthesis (Thoracolumbar region)
0.000 0.997 0.002
M43.14 Spondylolisthesis (Thoracic region)
0.000 0.997 0.002
M43.13 Spondylolisthesis (Cervicothoracic region)
0.000 0.997 0.002
M43.11 Spondylolisthesis (Occipito-atlanto-axial region)
0.000 0.997 0.002
M43.10 Spondylolisthesis (Multiple sites in spine)
0.000 0.997 0.002
C90.3 Solitary plasmacytoma
0.002 0.997 0.000
C90.1 Plasma cell leukaemia
0.002 0.997 0.000
R72 Abnormality of white blood cells, not elsewhere classified
0.003 0.997 0.000
G04.8 Other encephalitis, myelitis and encephalomyelitis
0.002 0.997 0.000
G04.2 Bacterial meningoencephalitis and meningomyelitis, not elsewhere classified
0.002 0.997 0.000
G04.1 Tropical spastic paraplegia
0.002 0.997 0.000
G04.0 Acute disseminated encephalitis
0.002 0.997 0.000
R70 Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity
0.002 0.997 0.000
N15.1 Renal and perinephric abscess
0.002 0.997 0.000
G06 Intracranial and intraspinal abscess and granuloma
0.002 0.997 0.000
G02 Meningitis in other infectious and parasitic diseases classified elsewhere
0.002 0.997 0.000
R78 Findings of drugs and other substances, not normally found in blood
0.002 0.997 0.000
H60.5 Acute otitis externa, non-infective
0.002 0.998 0.000
M41.8 Other forms of scoliosis
0.000 0.998 0.002
C71.7 Brain stem
0.002 0.998 0.000
C71.6 Cerebellum
0.002 0.998 0.000
C71.5 Cerebral ventricle
0.002 0.998 0.000
R70.0 Elevated erythrocyte sedimentation rate
0.002 0.998 0.000
G05 Encephalitis, myelitis and encephalomyelitis in diseases classified elsewhere
0.002 0.998 0.000
G00 Bacterial meningitis, not elsewhere classified
0.002 0.998 0.000
M43.12 Spondylolisthesis (Cervical region)
0.000 0.998 0.002
E04.2 Non-toxic multinodular goitre
0.002 0.998 0.000
N42.9 Disorder of prostate, unspecified
0.002 0.998 0.000
N80.2 Endometriosis of Fallopian tube
0.002 0.998 0.000
G02.0 Meningitis in viral diseases classified elsewhere
0.002 0.998 0.000
H60.3 Other infective otitis externa
0.002 0.998 0.000
G03 Meningitis due to other and unspecified causes
0.002 0.998 0.000
R79 Other abnormal findings of blood chemistry
0.002 0.998 0.000
G06.1 Intraspinal abscess and granuloma
0.002 0.998 0.000
R75 Laboratory evidence of human immunodeficiency virus [HIV]
0.002 0.998 0.000
E00-E07 Disorders of thyroid gland
0.002 0.998 0.000
G08 Intracranial and intraspinal phlebitis and thrombophlebitis
0.002 0.998 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2025 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.